Shaun P Forbes - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shaun P Forbes

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Current Medical Research and Opinion|August 2, 2023

Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphomaXiaoxiao Lu, Bruno Emond, Zaina P Qureshi, et al.

Journal of Medical Economics|July 22, 2024

Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherenceShaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, et al.

Journal of General Internal Medicine|September 29, 2022

Comparison of Low-Value Care Among Commercial and Medicaid EnrolleesJacqueline E Ellison, Soryan Kumar, Jon A Steingrimsson, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Current Medical Research and Opinion|August 2, 2023

Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphomaXiaoxiao Lu, Bruno Emond, Zaina P Qureshi, et al.

Journal of Medical Economics|July 22, 2024

Journal of General Internal Medicine|September 29, 2022

Comparison of Low-Value Care Among Commercial and Medicaid EnrolleesJacqueline E Ellison, Soryan Kumar, Jon A Steingrimsson, et al.

Pageof 2